IVRS was recently appointed as industry winners or ‘’Branschvinnare’’, which is awarded to Swedish companies who have reached exceedingly positive revenue and result changes during the year.
See what our CEO, Ramin Massoumi, had to say on the matter: Our mission has always been to bridge the gap between preclinical and clinical studies by offering flexible projects by using in vivo imaging, an approach that has been highly valued by our core market and customers. Our cutting-edge technology saves time and resources in any preclinical studies and data collection. We are excited to have received such an award, as it inspires the IVRS AB team to work even harder on communicating this innovative way of performing preclinical studies on broader demographic territories!
